Xoma Royalty Corporation · NASDAQ:XOMA
Ligand Pharmaceuticals Incorporated reported a 47.00% stake in Xoma Royalty Corporation (Schedule 13D)
Event Apr 27, 2026 · Filed May 1, 2026
Ligand Pharmaceuticals Incorporated reported a 47.00% stake in Xoma Royalty Corporation, 8,062,678 shares, with active intent on Apr 27, 2026. Filed May 1, 2026 (Schedule 13D).
- Stake
- 47.00%
- Shares
- 8,062,678
- Intent
- Active
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ligand Pharmaceuticals Incorporated | 47.00% | 8,062,678 |
Source
Related
- Xoma Royalty Corporation
- Ligand Pharmaceuticals Incorporated
- Xoma Royalty Corporation shareholders
- Schedule 13G/A · FMR LLC · Aug 7, 2026
- Schedule 13G/A · Morgan Stanley · Aug 7, 2026
- Schedule 13G/A · Morgan Stanley · Aug 7, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026